The WHO-EPI initiative for the global eradication of poliomyelitis.
Since the development of attenuated oral polio vaccine, Dr Albert Sabin consistently maintained that the global eradication of wild poliovirus was possible, but that to achieve polio eradication in developing countries would require the mass administration of the oral vaccine. Experience in Cuba and Czechoslovakia proved the effectiveness of this technique, but it was only with its deployment in Brazil in 1980 that its role in eradicating the virus from a broad geographical area started to be realized. With the declaration in 1985 of a target of regional polio eradication, extension of this policy, allied with the development of effective surveillance of acute flaccid paralysis in children, with laboratory confirmation of diagnosis rapidly led to apparent interruption of wild poliovirus transmission throughout the Americas. The World Health Assembly in 1988 committed WHO to the global eradication of poliomyelitis. Based on experience in the Americas and building on the solid foundation established by the Expanded Programme on Immunization, WHO has defined the strategies through which the global target could be achieved. Progress is encouraging and where the advocated strategies have been fully implemented, the incidence of poliomyelitis has declined dramatically. Significant geographical areas in Western Europe, the Maghreb, the Arabian peninsula, the Pacific basin and Southern Africa, each incorporating several countries, are now thought to be free of the disease caused by wild poliovirus. The target of a world free of polio by the year 2000 can be achieved.
Ward
N A
NA
Expanded Programme on Immunization, World Health Organization, Geneva, Switzerland.
Milstien
J B
JB
Hull
H F
HF
Hull
B P
BP
Kim-Farley
R J
RJ
D003906:Developing Countries; D004196:Disease Outbreaks; D014943:Global Health; D049673:History, 20th Century; D006801:Humans; D017589:Immunization Programs / Q000266:history; D015994:Incidence; D011051:Poliomyelitis / Q000453:epidemiology / Q000266:history / Q000517:prevention & control* / Q000635:transmission; D011055:Poliovirus Vaccine, Oral / Q000266:history / Q000627:therapeutic use*; D011159:Population Surveillance; D014480:United Nations; D014944:World Health Organization
D011055:Poliovirus Vaccine, Oral